CNS5:Oligodendroglioma, IDH-mutant and 1p/19q-codeleted: Difference between revisions
| [checked revision] | [checked revision] |
No edit summary |
No edit summary |
||
| Line 11: | Line 11: | ||
Shashirekha Shetty, PhD, Director, Cytogenetics Laboratory, Center for Human Genetics Laboratory, University Hospitals | Shashirekha Shetty, PhD, Director, Cytogenetics Laboratory, Center for Human Genetics Laboratory, University Hospitals | ||
==WHO Classification of Disease== | ==WHO Classification of Disease== | ||
| Line 33: | Line 32: | ||
|Subtype(s) | |Subtype(s) | ||
|Oligodendroglioma, IDH-mutant and 1p/19q-codeleted | |Oligodendroglioma, IDH-mutant and 1p/19q-codeleted | ||
|} | |||
==WHO Essential and Desirable Genetic Diagnostic Criteria== | |||
<span style="color:#0070C0">(''Instructions: The table will have the diagnostic criteria from the WHO book <u>autocompleted</u>; remove any <u>non</u>-genetics related criteria. If applicable, add text about other classification'' ''systems that define this entity and specify how the genetics-related criteria differ.'')</span> | |||
{| class="wikitable" | |||
|+ | |||
|WHO Essential Criteria (Genetics)* | |||
| | |||
|- | |||
|WHO Desirable Criteria (Genetics)* | |||
| | |||
|- | |||
|Other Classification | |||
| | |||
|} | |||
<nowiki>*</nowiki>Note: These are only the genetic/genomic criteria. Additional diagnostic criteria can be found in the [https://tumourclassification.iarc.who.int/home <u>WHO Classification of Tumours</u>]. | |||
==Related Terminology== | |||
<span style="color:#0070C0">(''Instructions: The table will have the related terminology from the WHO <u>autocompleted</u>.)''</span> | |||
{| class="wikitable" | |||
|+ | |||
|Acceptable | |||
| | |||
|- | |||
|Not Recommended | |||
| | |||
|} | |} | ||